TCGL:NYSEMKTTechCreate Group Ltd. Analysis
Data as of 2026-05-27 - not real-time
$172.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TechCreate Group Ltd. (TCGL) is trading at a price that vastly exceeds its underlying fundamentals. The stock’s price‑to‑book ratio is in the thousands and price‑to‑sales is in the high hundreds, while the company reports negative operating and net margins, and both operating and free cash flow are deeply in the red. Technical indicators reinforce the cautionary view: the Relative Strength Index is at an extreme high, the MACD histogram is negative and the signal line is bearish, and the 20‑day and 50‑day simple moving averages sit exactly at the current price, indicating a lack of directional momentum.
The recent fiscal‑year report highlighted a 54% revenue increase to roughly S$4.8 million, but this growth is modest compared to the market capitalization of over $3.5 billion. With a beta of roughly –2.4, the stock exhibits an inverse and highly volatile relationship to broader market moves, and the max drawdown of about 16% signals susceptibility to sharp declines. No dividend is paid, and analyst coverage is absent, further underscoring the speculative nature of the equity.
The recent fiscal‑year report highlighted a 54% revenue increase to roughly S$4.8 million, but this growth is modest compared to the market capitalization of over $3.5 billion. With a beta of roughly –2.4, the stock exhibits an inverse and highly volatile relationship to broader market moves, and the max drawdown of about 16% signals susceptibility to sharp declines. No dividend is paid, and analyst coverage is absent, further underscoring the speculative nature of the equity.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Extreme overbought RSI and bearish MACD signal
- Severe overvaluation relative to book and sales
- Negative cash flow and profitability
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued earnings deficits despite revenue growth
- High beta indicating inverse market sensitivity
- Lack of dividend and analyst coverage
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Fundamental financial weakness with negative margins
- Unsustainable valuation multiples
- Unclear path to profitability in a competitive tech‑infrastructure sector
Key Metrics & Analysis
Financial Health
Revenue Growth110.10%
Profit Margin-22.44%
ROE-17.86%
ROA-8.33%
Debt/Equity2.69
P/B Ratio4410.6
Op. Cash Flow$-5031822
Free Cash Flow$-2103698
Industry P/E40.4
Technical Analysis
TrendNeutral
RSI99.6
Support$172.84
Resistance$172.84
MA 20$172.84
MA 50$172.84
MA 200$93.65
MACDBearish
VolumeStable
Fear & Greed Index91.95
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta-2.42
0Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.